|
Volumn 37, Issue 4, 2001, Pages 1016-1018
|
Coronary artery bypass graft or percutaneous coronary interventions in patients with diabetes: Another nail in the coffin or "too close to call?"
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABCIXIMAB;
ANTITHROMBOCYTIC AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
LOW DENSITY LIPOPROTEIN;
SIMVASTATIN;
TIROFIBAN;
ANGIOCARDIOGRAPHY;
CLINICAL TRIAL;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
CORONARY STENT;
DIABETES MELLITUS;
EDITORIAL;
EMERGENCY SURGERY;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
LEFT ANTERIOR DESCENDING CORONARY ARTERY;
PRIORITY JOURNAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CORONARY ARTERY BYPASS;
CORONARY DISEASE;
DIABETES COMPLICATIONS;
HUMANS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0035869329
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/S0735-1097(01)01150-0 Document Type: Editorial |
Times cited : (5)
|
References (16)
|